Boeing
BA
$155.89
-2.88%
Boeing is a global aerospace and defense manufacturer operating three segments: Commercial Airplanes (competing with Airbus in the 130+ seat market), Defense, Space & Security (competing with Lockheed Martin and Northrop Grumman on military aircraft, satellites, and weaponry), and Global Services, which provides aftermarket support to airlines. As one of only two dominant Western commercial aircraft OEMs, Boeing functions as a duopoly participant with enormous barriers to entry, a massive installed base, and a backlog-driven business model, though its competitive identity has been dented by years of safety crises, quality lapses, and program delays that have ceded share to Airbus. The current investor narrative is a high-stakes turnaround debate: the October 27 earnings event sent shares down roughly 11% on lower production rates and missed delivery targets, resetting expectations around cash flow recovery, while bulls point to management's 2029 cash targets, a more contractor-friendly Pentagon posture, and defense wins as the basis for a multi-year earnings normalization. Sentiment is deeply bifurcated between patient long-term holders betting on execution recovery and skeptics who see recurring production and cash burn setbacks as evidence the turnaround timeline keeps slipping.…
BA
Boeing
$155.89
Related headlines
Investment Opinion: Should I buy BA Today?
Rating: Hold with a speculative-accumulation bias. The core thesis is that Boeing's $171.50 price already discounts a great deal of near-term execution failure — it sits just 3.8% above its $165.01 52-week low and 24.7% below where it started the year — while the Street's $233.35 average target (24 Buy, 3 Hold, 0 Sell, mean rating 1.41) implies roughly +36% upside if the production and cash-flow recovery merely proceeds on schedule. That is an attractive asymmetry on paper, but the evidence supporting it is forward-looking (2027-2029 normalization) rather than current, which argues for patience over aggressive buying at this exact price.
Four data points anchor the Hold. First, valuation on sales is at a multi-year floor: PS of 1.85x and EV/Sales of 1.73x versus a historical 4.5x-8.3x band and large-cap A&D peers typically at 2-3x. Second, the growth trajectory is weak but positive — Q3 2026 revenue of $24.19 billion grew 3.94% year-over-year, far below what a duopoly OEM should deliver off a trough, and sequentially flat ($22.22B, $24.56B, $24.19B). Third, profitability is deteriorating rather than recovering: gross margin fell from 11.46% in Q1 to 9.83% in Q2 to 8.96% in Q3, with operating income of just $139 million (0.57% margin) against $573 million of quarterly interest expense. Fourth, cash flow is volatile — TTM FCF of -$1.54 billion despite positive Q2 ($631M) and Q3 ($464M) after a -$1.45 billion Q1 burn — and the balance sheet (9.98x debt-to-equity, 1.19 current ratio, $9.54 billion cash) leaves limited room for another disruption.
The three biggest risks that would invalidate even a Hold are: (1) a Q4 delivery miss that forces consensus FY EPS of $11.95 toward the $11.35 low estimate, collapsing the 79.3x forward PE anchor; (2) continued gross margin compression below 9%, which would make the 'cheap on sales' argument a value trap rather than deep value; and (3) another financing event given negative TTM FCF and heavy debt service. This Hold would upgrade to Buy on evidence of gross margin recovering above 10% alongside accelerating deliveries, or on a pullback toward the $157 analyst low that widens the risk/reward; it would downgrade to Sell if the stock breaks the $165.01 52-week low on a delivery miss or if consensus EPS estimates are cut materially. Verdict: fairly valued to modestly undervalued on sales relative to history, but expensive on forward earnings relative to peers — the contradiction resolves only with execution.
Sign up to view all
BA 12-Month Price Forecast
The setup is a classic deep-value-versus-value-trap debate: Boeing is cheap on sales relative to its own history and peers, but expensive on the 79.3x forward PE that depends on an unproven jump from near-zero trailing EPS to $11.95. The bear case currently has stronger near-term evidence — three straight quarters of gross margin compression, a 3.94% revenue growth rate, negative TTM FCF, and a stock pinned at 7.3% of its 52-week range with -25.97% three-month momentum — while the bull case rests on a unanimous but potentially anchored analyst consensus and management's 2029 targets. The 94% target spread and the fact that ten major firms reiterated Buy through an 11% earnings-day plunge suggest the Street is valuing normalized 2027-2028 earnings, leaving the stock vulnerable to further estimate cuts if Q4 deliveries disappoint. I would upgrade to bullish on gross margin recovering above 10% with accelerating deliveries, or on a pullback toward the $157 analyst low that improves the risk/reward; I would downgrade to bearish on a break of the $165.01 52-week low or a material cut to the $11.95 consensus EPS.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Boeing's 12-month outlook, with a consensus price target around $233.35 and implied upside of +49.7% versus the current price.
Average Target
$233.35
27 analysts
Implied Upside
+49.7%
vs. current price
Analyst Count
27
covering this stock
Price Range
$157 - $305
Analyst target range
Coverage is broad and overwhelmingly bullish: 26 analysts with 24 Buy ratings, 3 Hold, and 0 Sell, producing a consensus recommendation of "strong_buy" (mean rating 1.41 on a 1-5 scale). The average target price of $233.35 implies roughly +36% upside from the current $171.50, a wide gap that signals the Street views the recent selloff as an overreaction to near-term execution issues rather than a structural break. The consensus leans decisively bullish, and the institutional ratings flow confirms it — ten major firms (Bernstein, Barclays, UBS, Wells Fargo, BNP Paribas, Jefferies, TD Cowen, RBC, JP Morgan, Susquehanna) all reiterated Outperform/Buy/Overweight/Positive ratings in late October 2026, with no downgrades in the visible data despite the 11% earnings-day plunge. That unanimity is itself a risk factor: when every analyst is bullish and the stock keeps falling, either the market is wrong or the analysts are anchored to stale models. The target range is extremely wide, from a low of $157 to a high of $305 — a 94% spread that signals high uncertainty about the pace of the recovery. The high target of $305 (roughly +78% upside) assumes successful production ramp, margin expansion toward historical levels, and a re-rating of the multiple as cash flow inflects; it effectively prices in the full 2029 management targets being met. The low target of $157 (about -8% downside) prices in continued production delays, margin compression, and cash burn — essentially a scenario where the turnaround slips another cycle. The wide dispersion, combined with the fact that the average target ($233) sits 36% above a stock trading near its 52-week low, suggests analysts are valuing Boeing on normalized 2027-2028 earnings rather than current fundamentals, leaving the stock vulnerable to further estimate cuts if Q4 deliveries disappoint. Consensus revenue estimates of ~$146 billion and EPS of ~$11.95 for the forward period imply a sharp acceleration from the current ~$96 billion run-rate, a bar that recent execution makes difficult to clear.
Bulls vs Bears: BA Investment Factors
The bear case currently carries stronger near-term evidence: margins are compressing sequentially (11.46% to 8.96% gross), revenue growth has stalled at 3.94%, TTM free cash flow is -$1.54 billion, and the stock is pinned near its 52-week low with accelerating negative momentum. The bull case rests almost entirely on forward-looking items — a 24-Buy/0-Sell analyst consensus with a $233.35 average target, a PS multiple at the bottom of its historical band, and management's 2029 cash targets — which are credible but unproven. The single most important tension is whether the commercial production ramp inflects before the balance sheet (9.98x debt-to-equity, 1.19 current ratio) forces another dilutive or expensive financing; if deliveries accelerate and gross margin recovers above 10%, the 79x forward PE becomes a normalization story, but if Q4 deliveries disappoint again, the $11.95 consensus EPS gets cut and the 'cheap on sales' argument loses its anchor. The 94% spread between the $157 low and $305 high targets is itself an admission that nobody knows the timing, and the unanimity of bullish ratings alongside a falling stock is a classic sign of anchored models.
Bullish
- Unanimous Street conviction, 36% upside: All 26 covering analysts carry 24 Buy, 3 Hold, and 0 Sell ratings, producing a 'strong_buy' consensus (mean 1.41) with an average target of $233.35 versus the $171.50 price — roughly +36% implied upside. Ten major firms including Bernstein, Barclays, UBS, Wells Fargo, and JP Morgan reiterated Outperform/Buy ratings in late October 2026 with no downgrades despite the 11% earnings-day plunge, suggesting the selloff is viewed as an overreaction rather than a structural break.
- PS multiple at multi-year floor: At 1.85x sales and 1.73x EV/Sales, Boeing trades at the very bottom of its historical 4.5x-to-8.3x PS band, a level not seen in the provided history. Against large-cap A&D peers typically at 2-3x sales, the discount is meaningful — and if margins normalize toward peer levels, the same revenue base would support a materially higher multiple.
- Cash flow inflecting positive sequentially: Quarterly free cash flow turned positive in Q2 2026 ($631 million) and Q3 2026 ($464 million) after a Q1 burn of -$1.45 billion, showing the working-capital swing can flip quickly. Management's 2029 cash targets, if met, underpin the ~14% annual return case cited in recent coverage even without multiple expansion.
- Defense tailwind from Pentagon posture: The Pentagon's shift toward more contractor-friendly contract terms is cited as a potential valuation re-rating catalyst for Boeing alongside Lockheed Martin and RTX. Defense, Space & Security generated $7.94 billion in Q3 2026 revenue — roughly a third of the total — giving Boeing meaningful leverage to improved contract economics.
Bearish
- Margins compressing quarter over quarter: Gross margin has deteriorated from 11.46% in Q1 2026 to 9.83% in Q2 to 8.96% in Q3, with operating income of just $139 million on $24.19 billion of revenue (0.57% operating margin). Against A&D peers at high-teens to low-20s gross margins, Boeing's profitability is a fraction of normal, and the trend is moving the wrong direction.
- Balance sheet stretched to the limit: Debt-to-equity stands at 9.98x with total debt at 87.5% of capitalization, a current ratio of only 1.19, and TTM free cash flow of -$1.54 billion. Interest expense of $573 million in Q3 alone consumes more than four times the quarter's operating income, leaving the company dependent on external financing and liquidity ($9.54 billion cash) rather than cash generation.
- Production ramp is stalling, not scaling: Revenue of $24.19 billion in Q3 2026 grew only 3.94% year-over-year and was roughly flat sequentially ($22.22B, $24.56B, $24.19B across Q1-Q3). The October 27 earnings event sent shares down ~11% on lower production rates and missed delivery targets, and Commercial Airplanes at $10.72 billion is the swing factor that refuses to accelerate.
- Valuation depends on an unproven EPS jump: The forward PE of 79.3x rests on consensus FY EPS of $11.95 versus trailing EPS of essentially zero ($0.0135), implying a dramatic earnings inflection that has not materialized. Consensus revenue of ~$146 billion versus the current ~$96 billion run-rate is a bar recent execution makes difficult to clear, leaving estimates vulnerable to further cuts.
BA Technical Analysis
Boeing is in a sustained downtrend, with the stock down 11.86% over the past year and 24.70% year-to-date, badly lagging the S&P 500's +12.27% one-year and +10.62% YTD returns. At the current price of $171.50, the stock sits at roughly 7.3% of its 52-week range of $165.01 to $254.35 — essentially pinned near the lows, which signals persistent selling pressure and a lack of buyers rather than a value cushion. The relative strength figures confirm the damage: -24.13% versus SPY over one year and -35.32% YTD, one of the weakest large-cap industrial performances in the market. Momentum is deteriorating, not stabilizing: the 1-month change of -7.13% and 3-month change of -25.97% show the decline accelerating into the recent period, with the 3-month figure far worse than the 6-month change of -22.22%, meaning most of the damage occurred in the last quarter. The 1-month relative strength of -4.87% versus SPY's -2.26% shows Boeing underperforming even in a soft tape, a bearish divergence that argues against calling this a mere mean-reversion pullback. The sharp gap down from $188.31 on October 26 to $168.18 on October 27 (an ~11% single-day drop on earnings) created an unfilled gap that now acts as overhead supply. Key support sits at the 52-week low of $165.01, just 3.8% below the current price; a breakdown there would signal a fresh leg lower and likely trigger momentum-driven selling. Resistance is layered: first the post-earnings gap zone around $188, then the 52-week high of $254.35, which is 48% above current levels and would require a fundamental re-rating to reclaim. With a beta of 1.331, Boeing is roughly 33% more volatile than the market, and a max drawdown of -33.71% over the period underscores the position-sizing risk — this is a high-beta, event-driven name where stops and sizing discipline matter more than in a defensive industrial.
Beta
1.33
1.33x market volatility
Max Drawdown
-38.2%
Largest decline past year
52-Week Range
$156-$254
Price range past year
Annual Return
-13.1%
Cumulative gain past year
| Period | BA Return | S&P 500 |
|---|---|---|
| 1m | -18.9% | -9.7% |
| 3m | -27.2% | -9.9% |
| 6m | -28.8% | -7.5% |
| 1y | -13.1% | +4.7% |
| ytd | -31.6% | +1.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BA Fundamental Analysis
Revenue is growing but modestly and unevenly: Q3 2026 revenue of $24.19 billion rose 3.94% year-over-year, continuing a slow recovery from the depressed 2024 base (Q4 2024 revenue was just $15.24 billion). Sequentially, revenue has been roughly flat — $22.22 billion in Q1, $24.56 billion in Q2, and $24.19 billion in Q3 2026 — suggesting the production ramp is stalling rather than accelerating, consistent with the missed delivery targets that cratered the stock in late October. Segment mix shows Commercial Airplanes at $10.72 billion, Defense, Space & Security at $7.94 billion, and Global Services at $5.57 billion; the commercial segment is the swing factor for the turnaround, and its inability to scale is the core bear case. The 3.94% growth rate is far below what a duopoly OEM should deliver coming off a trough, implying the investment case remains a 2027-2029 story rather than a current-year one. Profitability remains fragile: Q3 2026 net income was -$116 million (EPS -$0.26), with a gross margin of 8.96% and operating income of just $139 million on $24.19 billion of revenue (0.57% operating margin). Gross margin has compressed from 11.46% in Q1 2026 to 9.83% in Q2 to 8.96% in Q3 — a clear deteriorating trend that reflects unfavorable program mix and production inefficiencies. The Q4 2025 quarter showed a $8.22 billion net profit, but that was driven by a $9.13 billion non-operating gain (likely a tax valuation allowance release or divestiture), not operations — operating income that quarter was -$815 million, so the headline profit is not a sign of underlying health. Against an aerospace & defense industry where gross margins in the high teens to low 20s are typical, Boeing's 8.96% is deeply subpar and highlights how much margin recovery is embedded in the bull case. The balance sheet is the central risk: debt-to-equity stands at 9.98x, total debt to capitalization is 87.5%, and the current ratio of 1.19 is thin for a company with long production cycles. Free cash flow TTM is -$1.54 billion, and while quarterly FCF turned positive in Q2 ($631 million) and Q3 ($464 million) 2026, the Q1 burn of -$1.45 billion shows cash generation is volatile and dependent on working capital swings rather than durable earnings. Cash on hand was $9.54 billion at Q3-end versus heavy debt service (interest expense of $573 million in Q3 alone), and the reported ROE of 40.98% is a distortion of a near-zero or negative equity base rather than a sign of quality — ROA of -0.11% is the more honest profitability gauge. Boeing remains dependent on external financing and balance-sheet management to fund operations, and the negative TTM FCF means the dividend ($0.20 yield) and capex are effectively being funded from liquidity rather than cash generation.
Quarterly Revenue
$24.2B
2026-09
Revenue YoY Growth
+3.9%
YoY Comparison
Gross Margin
9.0%
Latest Quarter
Free Cash Flow
$16000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BA Overvalued?
Because trailing net income is barely positive (EPS of $0.0135) and quarterly results are loss-making, the trailing PE of 87.2x is not a meaningful anchor; the forward PE of 79.3x on consensus FY EPS of $11.95 is the more relevant metric, though even that is extremely rich. The enormous gap between the trailing PE (87x) and the forward PE (79x) implies the market expects a dramatic earnings inflection — consensus EPS of ~$11.95 versus trailing EPS of essentially zero — meaning investors are paying today for a 2027-2029 recovery that has not yet materialized. The PEG ratio of -0.77 is negative and therefore meaningless as a valuation signal given the loss-making base, reinforcing that earnings-based multiples are unreliable here and that price-to-sales is the cleaner lens. On sales, Boeing trades at a PS of 1.85x and EV/Sales of 1.73x, which is the most defensible valuation anchor given the revenue base of roughly $95-100 billion annualized. Against a sector where large-cap aerospace and defense peers typically trade at 2-3x sales with mid-teens operating margins, Boeing's 1.85x looks inexpensive — but that discount is earned, not a bargain, because its operating margin of 4.79% and gross margin of 4.79% (TTM basis) are a fraction of peer profitability. The EV/EBITDA of 28.4x is elevated for an industrial and reflects depressed EBITDA, while the P/B of 30.3x is distorted by a near-zero equity base and should be disregarded. Historically, Boeing's PS ratio has ranged from roughly 4.5x (Q3 2022) to 8.3x (Q4 2024), and the current 1.85x sits at the very bottom of that multi-year band — a level not seen in the provided history. That compression reflects both the falling share price and the rising revenue base, and it cuts two ways: it could signal deep value if the turnaround executes, or it could be the market correctly pricing persistent margin and cash-flow deterioration. The stock is cheap on sales relative to its own history but expensive on forward earnings relative to peers, a contradiction that only resolves if Boeing delivers the margin and cash-flow recovery embedded in consensus estimates.
PE
87.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
37.1x
Industry PE ~37.1x*
EV/EBITDA
28.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are acute and quantifiable. Debt-to-equity of 9.98x with 87.5% total-debt-to-capitalization and a current ratio of just 1.19 leaves little cushion for a company with multi-year production cycles, while TTM free cash flow of -$1.54 billion means the $0.20 dividend and capex are funded from the $9.54 billion cash pile rather than operations. Interest expense of $573 million in Q3 2026 dwarfs operating income of $139 million, so a single quarter of production disruption can swing the company back to meaningful cash burn — Q1 2026's -$1.45 billion FCF is the template. Revenue concentration in Commercial Airplanes ($10.72 billion of $24.19 billion) means the entire turnaround hinges on one segment's execution, and the sequential gross margin decline from 11.46% to 8.96% shows that even growing revenue is not translating into profitability. Market and competitive risks center on valuation compression and share loss. The forward PE of 79.3x on consensus EPS of $11.95 is extremely rich for an industrial, and the 94% spread between the $157 and $305 analyst targets signals that estimates are highly uncertain — any Q4 delivery miss would likely trigger the estimate cuts that the current price does not discount. Airbus continues to capitalize on Boeing's quality lapses, and the Pentagon's contractor-friendly shift benefits Lockheed Martin and RTX as much as Boeing, so it is not a differentiated catalyst. With a beta of 1.331, Boeing is roughly 33% more volatile than the market, and the -24.13% one-year relative strength versus SPY confirms it underperforms even in soft tapes — sector rotation out of troubled industrials would hit it disproportionately. The worst-case scenario is a chain in which Q4 deliveries miss again, consensus FY EPS of $11.95 is cut toward the $11.35 low estimate or below, and the market re-values the stock on cash burn rather than normalized earnings. In that path, the stock tests and breaks the 52-week low of $165.01 (just 3.8% below the current $171.50) and gravitates toward the $157 analyst low, a decline of roughly -8% to -9% from here; a broader risk-off tape combined with a failed production ramp could extend losses toward the -33.71% max drawdown observed over the period, implying a price near $114 in an extreme case. Position sizing should assume a realistic 10-35% downside range before any recovery materializes.
FAQ
Ranked by severity, the first risk is balance-sheet and cash-flow fragility: debt-to-equity of 9.98x, total debt at 87.5% of capitalization, a 1.19 current ratio, and TTM free cash flow of -$1.54 billion mean another production disruption could force dilutive or expensive financing, especially with $573 million of quarterly interest expense against $139 million of operating income. Second is execution risk concentrated in Commercial Airplanes ($10.72 billion of $24.19 billion in Q3 revenue), where the October 27 earnings event drove an ~11% single-day drop on lower production rates and missed deliveries, and where gross margin has compressed for three straight quarters. Third is valuation/estimate risk: the 79.3x forward PE depends on consensus EPS of $11.95 versus $0.0135 trailing, and the 94% spread between the $157 and $305 analyst targets shows how uncertain those models are — a Q4 miss would likely trigger the estimate cuts the price does not discount. Fourth is competitive and macro risk: Airbus continues to capitalize on Boeing quality lapses, the Pentagon's contractor-friendly shift benefits Lockheed Martin and RTX equally rather than being a differentiated catalyst, and a beta of 1.331 with -24.13% one-year relative strength versus SPY means sector rotation out of troubled industrials hits Boeing disproportionately.
The scenario framework assigns a 55% probability to the base case of $185-$233, a 25% probability to the bear case of $140-$165, and a 20% probability to the bull case of $233-$305. The base case is most likely: revenue grows in the low-to-mid single digits from the ~$96 billion run-rate (well short of the ~$146 billion consensus bar), gross margin stabilizes in the 9-11% range, free cash flow oscillates around breakeven, and the stock trades between the post-earnings gap zone near $188 and the $233 average target. The bear case requires a second consecutive Q4 delivery disappointment that pushes consensus EPS toward the $11.35 low estimate and breaks the $165.01 52-week low, with the $157 analyst low as the first waypoint and an extended drawdown potentially reaching near $114. The bull case requires deliveries to accelerate, gross margin to recover above 10%, and free cash flow to turn durably positive, allowing a re-rating toward $233 and, if management's 2029 cash targets gain credibility, toward the $305 high target. The key assumption behind the base case is that the recovery proceeds on schedule but not fast enough to prevent further estimate trimming.
The answer depends entirely on which lens you use, and that contradiction is the heart of the debate. On sales, Boeing looks cheap: PS of 1.85x and EV/Sales of 1.73x sit at the very bottom of a historical 4.5x-8.3x band and below large-cap A&D peers typically at 2-3x, a discount that reflects its 4.79% operating margin versus peer high-teens profitability. On earnings, it looks expensive: the 79.3x forward PE on $11.95 of consensus EPS is rich for an industrial, the 28.4x EV/EBITDA reflects depressed EBITDA, and the 30.3x P/B is distorted by a near-zero equity base and should be ignored. The trailing PE of 87.2x and negative PEG of -0.77 are not meaningful anchors given the loss-making base. What the market is effectively pricing is a successful production ramp and margin recovery — the 1.85x sales multiple says investors are unwilling to pay for that recovery today, while the 79x forward PE says they will pay heavily if it arrives. Verdict: modestly undervalued on sales relative to its own history, expensive on forward earnings relative to peers, and fairly valued only if execution improves.
From a pure risk/reward standpoint the setup is asymmetric but unproven: at $171.50 the stock is 3.8% above its $165.01 52-week low and the $233.35 average analyst target implies about +36% upside, while the $157 low target implies only about -8% downside to the first waypoint. The catch is that the upside depends on 2027-2029 normalization rather than current fundamentals — gross margin has fallen from 11.46% to 8.96% across Q1-Q3 2026, TTM free cash flow is -$1.54 billion, and the 79.3x forward PE rests on an unproven jump from $0.0135 trailing EPS to $11.95. The biggest downside risk is a Q4 delivery miss that cuts that consensus EPS and breaks the 52-week low, with an extended risk-off tape potentially stretching losses toward the -33.71% max drawdown. It is a reasonable buy only for patient, risk-tolerant investors with a multi-year horizon who can tolerate a 10-35% drawdown and who size the position for a beta of 1.331; it is not a good buy for anyone needing near-term earnings support or income.
Boeing is structurally a long-term holding and a poor short-term trading vehicle for most investors. The earnings visibility is very low — trailing EPS of $0.0135, three consecutive quarters of negative net income (-$4 million, -$444 million, -$116 million), and a 94% spread between the $157 and $305 analyst targets — which means near-term price action is driven by delivery headlines and estimate revisions rather than fundamentals, as the ~11% October 27 earnings-day drop demonstrated. The beta of 1.331 and -33.71% max drawdown make it roughly a third more volatile than the market, and the 0.20% dividend yield provides essentially no income cushion, so short-term holders are taking event risk without compensation. The bull case explicitly depends on 2027-2029 cash targets and normalized 2027-2028 earnings, which argues for a minimum holding period of at least 24-36 months to let the production ramp and margin recovery play out. A reasonable approach is a small starter position now with planned additions on evidence of gross margin recovering above 10% or on a pullback toward the $157 analyst low, rather than a full position at $171.50.

